Apraxia of Speech
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Apraxia of Speech trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Apraxia of Speech trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treat…
The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder aff…
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, ne…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphi…
This protocol is designed to enable access to intravenous infusions of banked umbilical cord blood (CB), that is thawed and not more than minimally manipulated,…
This is a 20-week study for children between 3 and 6 years old with confirmed childhood apraxia of speech (CAS). The study includes a 12-week open-label pilot f…
Childhood apraxia of speech (CAS) is a complex motor speech disorder that significantly limits a child's ability to communicate in daily activities, with diffic…